Routine Intraoperative Bacterial Culture May Be Needed in Complicated Appendicitis

다국어 초록 (Multilingual Abstract)

Purpose: Choosing the appropriate antibiotic is important for treatment of complicated appendicitis. However, increasing multidrug resistant bacteria have been a serious problem for successful treatment. This study was designed to identify bacteria isolated from patients with complicated appendicitis and reveal their susceptibilities for antibiotics and their relationship with patient clinical course.
Methods: This study included patients diagnosed with complicated appendicitis and examined the bacterial cultures and antimicrobial susceptibilities of the isolates. Data were retrospectively collected from medical records of Kangbuk Samsung Hospital from January 2008 to February 2018.
Results: The common bacterial species cultured in complicated appendicitis were as follows: Escherichia coli (n=113, 48.9%), Streptococcus spp. (n=29, 12.6%), Pseudomonas spp. (n=23, 10.0%), Bacteriodes spp. (n=22, 9.5%), Klebsiella (n=11, 4.8%), and Enterococcus spp. (n=8, 3.5%). In antibiotics susceptibility testing, the positive rate of extended-spectrum beta lactamase (ESBL) was 9.1% (21 of 231). The resistance rate to carbapenem was 1.7% (4 of 231), while that to vancomycin was 0.4% (1 of 231). E. coli was 16.8% ESBL positive (19 of 113) and had 22.1% and 19.5% resistance rates to cefotaxime and ceftazidime, respectively. Inappropriate empirical antibiotic treatment (IEAT) occurred in 55 cases (31.8%) and was significantly related with organ/space surgical site infection (SSI) (7 of 55, P=0.005).
Conclusion: The rate of antibiotic resistance organisms was high in community-acquired complicated appendicitis in Koreans. Additionally, IEAT in complicated appendicitis may lead to increased rates of SSI. Routine intraoperative culture in patients with complicated appendicitis may be an effective strategy for appropriate antibiotic regimen.

참고문헌 (Reference)

1 Di Saverio S, "WSES Jerusalem guidelines for diagnosis and treatment of acute appendicitis" 11 : 34-, 2016

2 Kenig J, "The need for culture swabs in laparoscopically treated appendicitis" 8 : 310-314, 2013

3 Sartelli M, "The management of intra-abdominal infections from a global perspective : 2017 WSES guidelines for management of intra-abdominal infections" 12 : 29-, 2017

4 Addiss DG, "The epidemiology of appendicitis and appendectomy in the United States" 132 : 910-925, 1990

5 Tan A, "The appropriateness of ceftriaxone and metronidazole as empirical therapy in managing complicated intra-abdominal infection-experience from Western Health, Australia" 6 : e5383-, 2018

6 St Peter SD, "Single daily dosing ceftriaxone and metronidazole vs standard triple antibiotic regimen for perforated appendicitis in children : a prospective randomized trial" 43 : 981-985, 2008

7 Akingboye AA, "Pus Samples in complicated appendicitis : an important investigation or a waste of resources : a prospective cohort study" 108 : 55-60, 2019

8 Kang CI, "Piperacillintazobactam as an initial empirical therapy of bacteremia caused by extended-spectrum β-lactamase-producing Escherichia coli and Klebsiella pneumoniae" 64 : 533-534, 2012

9 Davies HO, "Peritoneal fluid culture in appendicitis : review in changing times" 8 : 426-429, 2010

10 Celik A, "Is it justified to obtain routine peritoneal fluid cultures during appendectomy in children?" 19 : 632-634, 2003

11 Foo FJ, "Intra-operative culture swabs in acute appendicitis : a waste of resources" 6 : 278-281, 2008

12 Gladman MA, "Intra-operative culture in appendicitis : traditional practice challenged" 86 : 196-201, 2004

13 Bochicchio GV, "In vitro susceptibilities of Escherichia coli isolated from patients with intra-abdominal infections worldwide in 2002-2004: results from SMART (Study for Monitoring Antimicrobial Resistance Trends)" 7 : 537-545, 2006

14 Solomkin JS, "Diagnosis and management of complicated intraabdominal infection in adults and children : guidelines by the Surgical Infection Society and the Infectious Diseases Society of America" 50 : 133-164, 2010

15 Gavin PJ, "Clinical correlation of the CLSI susceptibility breakpoint for piperacillin-tazobactam against extended-spectrum-beta-lactamase-producing Escherichia coli and Klebsiella species" 50 : 2244-2247, 2006

16 Cardoso T, "Classification of healthcare-associated infection : a systematic review 10 years after the first proposal" 12 : 40-, 2014

17 Kariv G, "Benchmarking inappropriate empirical antibiotic treatment" 19 : 629-633, 2013

18 Reinisch A, "Bad bacteria in acute appendicitis : rare but relevant" 32 : 1303-1311, 2017

19 Chen CY, "Bacteriology of acute appendicitis and its implication for the use of prophylactic antibiotics" 13 : 383-390, 2012

20 Jeon HG, "Bacteriology and changes in antibiotic susceptibility in adults with community-acquired perforated appendicitis" 9 : e111144-, 2014

21 Sartelli M, "Antimicrobial management of intra-abdominal infections : literature’s guidelines" 18 : 865-871, 2012

22 Coccolini F, "Antibiotic resistance evaluation and clinical analysis of acute appendicitis; report of 1431 consecutive worldwide patients : A cohort study" 26 : 6-11, 2016

23 Peterson LR, "Antibiotic policy and prescribing strategies for therapy of extended-spectrum beta-lactamase-producing Enterobacteriaceae: the role of piperacillin-tazobactam" 14 (14): 181-184, 2008